Transmembrane pH-Gradient Vesicles via Osmotic Shock
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing transmembrane pH-gradient vesicles, such as liposomes, face challenges in maintaining stability over time due to diffusion and degradation of lipid components, especially during sterilization processes involving heat, which disrupt the pH gradient and are costly or difficult to scale up industrially.
Innovation Solution
A method involving the preparation of vesicles in an aqueous medium with controlled osmolarity, followed by an osmotic shock with a hyperosmotic buffer to incorporate a buffer inside the vesicles, and subsequent dilution to establish a transmembrane pH gradient without requiring high temperatures, ensuring stability and sterility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If sterilization is performed on the final formulation containing encapsulated compound, then sterility is achieved, but the transmembrane pH gradient decreases due to diffusion and degradation of lipid components
Solution Approach 1:
The patent applies preliminary sterilization to the aqueous medium before vesicle formation, rather than sterilizing the final formulation. This allows the vesicles to be formed in a sterile environment without exposing them to high temperatures that would degrade the lipid components and dissipate the pH gradient. The sterilization is performed in advance on the medium that will become the vesicle interior, maintaining both sterility and gradient stability.
Solution Approach 2:
The patent segments the sterilization process from the vesicle formation process. Instead of a single combined sterilization step at the end, the sterilization is separated and performed on the aqueous medium beforehand. This segmentation allows each process to be optimized independently - sterilization can be thorough while vesicle formation can occur under gentle conditions that preserve the pH gradient.
2Reliability
If sterilization is performed under high temperatures, then sterility is achieved, but chemical degradation of liposomal components is accelerated
Solution Approach 1:
The patent performs sterilization as a preliminary action on the aqueous medium before vesicle formation. The medium is sterilized by autoclaving or other high-temperature methods, then cooled and used to hydrate the lipid film. The vesicles themselves are never exposed to high temperatures, protecting the lipid components from thermal degradation while still achieving sterility of the final product through the sterile medium.
3Quantity of substance
If transmembrane loading is achieved by heating above membrane lipid transition temperature, then substance incorporation is improved, but membrane destabilization occurs and pH gradient is disrupted
Solution Approach 1:
The patent extracts the heating step from the substance incorporation process. Instead of heating the vesicles to incorporate substances, the patent uses a different mechanism: substances are incorporated during vesicle formation in the aqueous medium, or through osmotic shock methods that do not require thermal destabilization. This removes the harmful thermal effect while maintaining effective substance loading.
Solution Approach 2:
The patent changes the parameter used for substance incorporation from temperature to osmolarity. By using osmotic shock with hyperosmotic solutions, the patent achieves membrane permeabilization and substance uptake without thermal heating. This parameter change from thermal to osmotic mechanisms allows effective loading while preserving membrane integrity and pH gradient stability.
4Reliability
If freeze drying is used to prepare sterile liposomes, then sterility and stability are improved, but process complexity and cost increase
Solution Approach 1:
The patent performs preliminary sterilization of the aqueous medium before vesicle formation, eliminating the need for subsequent freeze-drying sterilization steps. The vesicles are formed directly in the pre-sterilized medium and can be used immediately or stored without complex lyophilization equipment and procedures, reducing both device complexity and process cost while maintaining sterility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces stable transmembrane pH-gradient vesicles that maintain their gradient over time, suitable for industrial applications, and can be scaled up efficiently without the need for high-temperature destabilization, enhancing their use as biodetoxifying agents.
Implementation Method 1
vesicles made from at least one matrix substance are prepared in an aqueous medium having an osmolarity of not more than 200 mOsm/l
Implementation Method 2
The resulting osmotic pressure difference between the inside and outside of the vesicles causes the vesicles to swell
Implementation Method 3
the vesicles are mixed with a basic or acidic buffer having an osmolarity being at least 200 mOsm/l higher than the osmolarity of the aqueous medium of step a) to apply an osmotic shock to the vesicles
Implementation Method 4
The resulting osmotic pressure difference between the inside and outside of the vesicles causes the vesicles to swell
Data Source
AI summary
A method for preparing transmembrane pH-gradient vesicles is provided. This method includes the following steps: a) preparing vesicles made from at least one matrix substance in an aqueous medium having an osmolarity of not more than 200 mOsm/l, wherein the matrix substance is chosen from the group consisting of amphiphilic lipids and amphiphilic block copolymers, b) transferring the vesicles into a basic or acidic buffer having an osmolarity being at least 200 mOsm/l higher than the osmolarity of the aqueous medium of step a) to apply an osmotic shock to the vesicles and to obtain buffer-filled vesicles and c) diluting a mixture of the aqueous medium and the basic or acidic buffer containing the buffer-filled vesicles by adding a neutralizing solution to obtain transmembrane pH-gradient vesicles suspended in a suspension buffer, wherein the suspension buffer differs from the basic or acidic buffer in pH value.